130 results
Page 6 of 7
6-K
EX-99.3
q203ca23tvh4lj4q
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
ri57brvx0u1ixgw5hu
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
0l2zuy20xf4a
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.6
x68tbs4 9lk4gpz0
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.2
bfxmyzyu 2ow
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
s690xo
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
3cj6t84 n0gd711s744
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
1dtrt6 yb
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
6-K
EX-99.1
veiunlix3e0x27
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
yg5murpqhp95d
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
a4kvsl0e0r
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
4yf6hl57
8 Jan 21
Registration statement (foreign)
4:58pm
F-1
EX-5.1
8kxeab 0yvbs5obm
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
pccrjuo7u8k5
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
pnqt64d4y
17 Dec 20
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
6:15am
6-K
729a 6qrb8
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
q6irghm
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.1
org01gp8kc jtpqk
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
EX-99.1
o1omp4mm 2n9zdvq
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
olza4x23
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am